John Wiley & Sons, Inc.

Hoboken, NJ Information & technologyNAICS 511130

Self-funded health planPlan year 2025Renews January
2,027Participants+2% vs. prior year
$4.8MEst. pharmacy spend / yrParticipants × national avg.
Jan 2027Next renewalPlan year begins January 1
#2 of 7Information & technology in NJBy participants

Overview

John Wiley & Sons, Inc. sponsors a self-funded health plan that covered 2,027 participants in plan year 2025, up 2% from the prior year. The plan year starts in January. Alongside medical, its benefits filing reports life insurance, dental, vision, short-term disability, and more.

Plan type
ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
Participants
2,027 · prior year 1,980
Plan year
Begins January 1 · next renewal January 2027
Health plans filed
John Wiley & Sons, Inc. Group Life and Health Plan, plan 504 (2,027 participants)
Stop-loss carrier
Aetna Life Insurance Co.
Broker compensation
$184K across insured contracts
MedicalLife insuranceDentalVisionShort-term disabilityLong-term disabilitySeveranceDeath benefitsOther welfare benefits

Insurance carriers

Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.

CarrierCoverageCoveredPremiumBroker comp
Aetna Life Insurance Co.Stop-loss1,367$967K$49K
Lincoln National Life Insurance CompanyLong-term disability, Life1,902$542K$52K
Kaiser Foundation Health Plan Inc.Medical, Prescription drug, HMO46$387K$8K
American Heritage Life Insurance CompanyLife, Accident, Critical Illness529$309K$47K
Vision Service PlanVision1,135$244K$12K
Cigna Health and Life Insurance Company and AffiliatesDental, HMO719$174K$10K
Federal Insurance CompanyBusiness Travel Accident1,902$16K$3K

Pharmacy benefit estimate

StreamRX estimate for a plan this size. Not based on this plan's claims.

$4.8M/ year

Estimated prescription spend: 2,027 participants × $2,371 national average per member. Usually higher once dependents are counted.

$125K–$308K/ year

Typical savings opportunity found in independent reviews of plans this size.

Brands with a generic available$37K–$91K
Lower-cost therapeutic alternatives$53K–$111K
Generic pricing vs. actual cost$23K–$69K
PBM contract terms$12K–$36K
The DOL's PBM fee disclosure rule first applies to this plan for the plan year beginning January 2028: semiannual PBM compensation reports and an annual audit right.

Form 5500 filing details

Filing
Form 5500 with Schedule A, plan year 2025
Plan sponsor
John Wiley & Sons, Inc.
Sponsor EIN
13-5593032
Plan number
504
Filed with
U.S. Department of Labor (EBSA) via EFAST2

Verify this filing: search EIN 13-5593032 in the Department of Labor's EFAST2 Form 5500 search.

Retirement plan

Plan
John Wiley & Sons, Inc. Employees' Savings Plan
Type
401(k) plan
Participants
4,568

About this data

Source: John Wiley & Sons, Inc.'s Form 5500 filing for plan year 2025 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with John Wiley & Sons, Inc..

Request a correction · Methodology